- Home
- IPI vs OBIO Comparison
IPI vs OBIO Comparison
Compare IPI & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPI
- OBIO
- Stock Information
- Founded
- IPI 2000
- OBIO 2017
- Country
- IPI United States
- OBIO United States
- Employees
- IPI N/A
- OBIO N/A
- Industry
- IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- IPI Industrials
- OBIO Health Care
- Exchange
- IPI Nasdaq
- OBIO Nasdaq
- Market Cap
- IPI 475.8M
- OBIO 118.8M
- IPO Year
- IPI 2008
- OBIO N/A
- Fundamental
- Price
- IPI $35.05
- OBIO $2.96
- Analyst Decision
- IPI Strong Sell
- OBIO Strong Buy
- Analyst Count
- IPI 1
- OBIO 5
- Target Price
- IPI $19.00
- OBIO $14.20
- AVG Volume (30 Days)
- IPI 144.2K
- OBIO 369.1K
- Earning Date
- IPI 08-04-2025
- OBIO 08-11-2025
- Dividend Yield
- IPI N/A
- OBIO N/A
- EPS Growth
- IPI N/A
- OBIO N/A
- EPS
- IPI N/A
- OBIO N/A
- Revenue
- IPI $217,865,000.00
- OBIO $2,886,000.00
- Revenue This Year
- IPI $11.06
- OBIO $20.47
- Revenue Next Year
- IPI N/A
- OBIO $11.45
- P/E Ratio
- IPI N/A
- OBIO N/A
- Revenue Growth
- IPI N/A
- OBIO 30.23
- 52 Week Low
- IPI $20.75
- OBIO $2.37
- 52 Week High
- IPI $39.01
- OBIO $8.87
- Technical
- Relative Strength Index (RSI)
- IPI 42.90
- OBIO 51.30
- Support Level
- IPI $35.84
- OBIO $2.78
- Resistance Level
- IPI $37.84
- OBIO $2.94
- Average True Range (ATR)
- IPI 1.20
- OBIO 0.21
- MACD
- IPI -0.12
- OBIO -0.00
- Stochastic Oscillator
- IPI 23.35
- OBIO 60.87
About IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.